PER 1.18% 8.6¢ percheron therapeutics limited

I think this is positive news for ATL1102. The FDA isn't...

  1. 4,321 Posts.
    lightbulb Created with Sketch. 2019
    I think this is positive news for ATL1102.

    The FDA isn't needing a cure to be proven before a drug is approved. It just needs to see results equal to SOC.

    So as long as PER can show its drug can match or better the results of steriods it should gain approval.

    Its Safety and proof of out performing steriods would help gain market share. And we have preclinical trial data that shows ATL1102 will work even when the patient has prior gene therapy.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.6¢
Change
0.001(1.18%)
Mkt cap ! $77.53M
Open High Low Value Volume
8.5¢ 8.8¢ 8.4¢ $18.63K 218.7K

Buyers (Bids)

No. Vol. Price($)
1 30000 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 46681 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.